AIM’s Latest Newsletter: The Research Edition, July 2023
Published:
08/01/2023

This month’s newsletter focuses on the latest news and scientific breakthroughs in melanoma research.
This edition features:
- Letter from AIM’s President, Sam Guild
- Notes From the Lab: Novel Targets for Immune Checkpoint Inhibitors
By Paul Bunk, Ph.D. candidate, Cold Springs Harbor Laboratory - In Plain English: Neoadjuvant Therapy for Melanoma, and How We Got Here
By Kim Margolin, M.D., FACP, FASCO - Clinical Trials Catch Up: An Interview with Joshua M.V. Mammen, M.D., Ph.D., F.A.C.S.
By Alicia Rowell, Vice President, AIM at Melanoma
Recent Posts

Feb. 14, 2025
Men and Women and Melanoma: Who’s Winning the Battle?

Feb. 06, 2025
Genetic Testing Performed in Melanoma

Jan. 21, 2025
Replimune Announces BLA Acceptance and Priority Review for RP1 for the Treatment in Advanced Melanoma

Jan. 14, 2025
Meaning-Centered Psychotherapy: Finding Purpose in the Face of Cancer

Jan. 09, 2025